acetylcysteine has been researched along with Heart Failure in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (14.29) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 9 (21.43) | 29.6817 |
| 2010's | 19 (45.24) | 24.3611 |
| 2020's | 5 (11.90) | 2.80 |
| Authors | Studies |
|---|---|
| Khansari, N; Mehrpooya, M; Mohammadi, Y; Yazdi, A; Zareie, S | 1 |
| Hirata, Y; Isagawa, T; Kido, Y; Komuro, I; Manabe, I; Nakagama, Y; Okamura, K; Ono, M; Sakamoto, M; Sato, T; Soma, K; Takeda, N | 1 |
| Amin, A; Barón, AE; Gilmartin, HM; Keach, JW; Langner, P; Maddox, TM; Plomondon, ME; Stanislawski, MA; Waldo, S | 1 |
| Huang, CH; Jiang, SJ | 1 |
| McCarty, MF | 2 |
| Chi, RF; Li, B; Li, L; Qin, FZ; Wang, AL; Wang, K; Xi, J; Yang, H; Yang, LG; Zhang, C; Zhu, ZF | 1 |
| Choi, YJ; Lee, J; Lee, YS; Park, WY; Seo, SW; Shim, DM | 1 |
| Campos, DHS; Damatto, FC; Damatto, RL; Depra, I; Fernandez, AAH; Gomes, MJ; Martinez, PF; Okoshi, K; Okoshi, MP; Pagan, LU; Reyes, DRA; Rosa, CM | 1 |
| Bonne, G; Decostre, V; Hutchison, CJ; Khouzami, L; Muchir, A; Pecker, F; Pekovic-Vaughan, V; Rodriguez, BM; Varnous, S | 1 |
| Inchina, VI; Konorev, VV; Kuz'michev, ND; Kuznetsov, YV; Zamotaeva, MN | 1 |
| Luo, AY; Ren, JH; Wu, XY; Zhou, YR | 1 |
| Bonomo, C; Cezar, MD; Damatto, RL; Fernandes, DC; Guizoni, DM; Junior, SA; Laurindo, FR; Lima, AR; Martinez, PF; Matsubara, LS; Novelli, EL; Okoshi, K; Okoshi, MP; Pagan, LU; Seiva, FR; Zornoff, LA | 1 |
| Dalton, ND; Divakaruni, AS; Dorn, GW; Gray, CB; Gu, Y; Heller Brown, J; Ling, H; Matkovich, SJ; Miyamoto, S; Murphy, AN; Peterson, KL; Westenbrink, BD; Zambon, AC | 1 |
| Andreu, AL; Barreiro, E; Chacón-Cabrera, A; García-Arumí, E; Marin-Corral, J; Mateu, X; Molina, L; Puente-Maestu, L; Puig-Vilanova, E; Salazar-Degracia, A | 1 |
| Solomon, R | 1 |
| Chu, PY; Du, XJ; Giam, B; Horlock, D; Kaye, DM; Kiriazis, H; Kuruppu, S; Rajapakse, NW; Smith, AI | 1 |
| Furukawa, T; Isobe, M; Kato, N; Kurokawa, J; Okamura, T; Sasano, T; Sugiyama, K; Takahashi, K | 1 |
| Bonomo, C; Bueno, RT; Cezar, MD; Damatto, RL; Fernandes, DC; Guizoni, DM; Junior, SA; Laurindo, FR; Lima, AR; Martinez, PF; Okoshi, K; Okoshi, MP; Pagan, LU; Seiva, FR; Zornoff, LA | 1 |
| Abdel-Qadir, H; Amir, E; Fazelzad, R; Lee, DS; Ong, G; Thavendiranathan, P; Tomlinson, G | 1 |
| Cardounel, AJ; Carnes, CA; Gyorke, S; Hamlin, RL; Khan, M; Nakayama, T; Nishijima, Y; Sridhar, A; Terentyev, D; Terentyeva, R | 1 |
| Cass, A; Gallagher, M; Huxley, R; Jardine, M; Ninomiya, T; Patel, A; Perkovic, V; Sadigh, G; Vasheghani-Farahani, A; Zoungas, S | 1 |
| Dalic, A; Dart, AM; Drummond, G; Du, XJ; Fang, L; Gao, XM; Kiriazis, H; Ritchie, RH; Sarwar, M; Sim, K; Xu, Q; Zhang, YY | 1 |
| Altieri, PI; Crespo, MJ; Cruz, N; Escobales, N | 1 |
| Adams, V; Blase, P; Desch, S; Droppa, M; Eitel, I; Fuernau, G; Schuler, G; Thiele, H | 1 |
| Andre, L; Cazorla, O; Farah, C; Fauconnier, J; Feillet-Coudray, C; Fouret, G; Lacampagne, A; Meschin, P; Reboul, C; Richard, S | 1 |
| Genest, M; Pochmalicki, G | 1 |
| Adamy, C; Bourin, MC; Candiani, G; Defer, N; Hittinger, L; Kirsch, M; Le Corvoisier, P; Pavoine, C; Pecker, E; Su, JB; Vermes, E | 1 |
| Beebe, S; Hargrave, BY; Kerry, J; Lattanzio, FA; Osgood, C; Tiangco, D | 1 |
| Adamy, C; Andrieu-abadie, N; Berdeaux, A; Candiani, G; Caramelle, P; Damy, T; Defer, N; Hittinger, L; Khouzami, L; Kirsch, M; Le Corvoisier, P; Levade, T; Mulder, P; Pavoine, C; Pecker, F; Perier, M; Souktani, R; Thuillez, C | 1 |
| Erley, C | 1 |
| Azroyan, A; Defer, N; Pavoine, C; Pecker, F | 1 |
| Dangas, G; Mehran, R; Pucelikova, T | 1 |
| Campana, C; Diotallevi, P; Eleuteri, E; Ferrario, M; Ghio, S; Montemartini, C; Mussini, A; Poli, A; Specchia, G | 1 |
| Elkayam, U; Hsueh, W; Mehra, A; Ostrzega, E; Shotan, A; Vasquez-Johnson, J | 1 |
| Wynne, JW | 1 |
| Dupuis, J; Lalonde, G; Lemieux, R; Rouleau, JL | 1 |
| Bodemann, T; Hochrein, H; Langescheid, C | 1 |
| Gottlieb, SS; Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 1 |
| Balcerzak, SP; Hamlin, RL; Leier, CV; Unverferth, DV | 1 |
| Giordano, MP; Roncarolo, PL | 1 |
| Margolis, J; Margolis, LS | 1 |
9 review(s) available for acetylcysteine and Heart Failure
| Article | Year |
|---|---|
The Clinical Efficacy of N-Acetylcysteine in the Treatment of ST Segment Elevation Myocardial Infarction.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Creatine Kinase, MB Form; Female; Free Radical Scavengers; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction; Stroke Volume; Treatment Outcome; Troponin T | 2021 |
Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.
Topics: Acetylcysteine; Animals; Antioxidants; Diet; Dietary Supplements; Endoplasmic Reticulum Stress; Exercise; Fibroblast Growth Factor-23; Functional Food; Heart Failure; Humans; Hypertrophy, Left Ventricular; Life Style; Nitric Oxide; Oxidative Stress | 2021 |
Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensins; Anthracyclines; Cardiomyopathies; Clinical Trials as Topic; Dexrazoxane; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasms; Network Meta-Analysis; Prenylamine; Ventricular Dysfunction, Left | 2017 |
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
Topics: Acetylcysteine; Contrast Media; Heart Failure; Humans; Injections, Intravenous; Kidney Diseases; Mortality; Renal Dialysis; Risk; Sodium Bicarbonate | 2009 |
Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Atrial Fibrillation; Fibrosis; Heart Failure; Humans; Mitochondria; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Superoxides | 2010 |
[Diagnostic and therapeutic progress. Venous thromboembolism, cardiac insufficiency and radio contrast agents].
Topics: Acetylcysteine; Acute Disease; Adrenergic beta-Antagonists; Anticoagulants; Counterpulsation; Diastole; Diuretics; Echocardiography; Electric Countershock; Fibrin Fibrinogen Degradation Products; Fluid Therapy; Heart Failure; Hemofiltration; Heparin; Humans; Kidney Failure, Chronic; Natriuretic Peptide, Brain; Oxygen Inhalation Therapy; Pulmonary Edema; Thromboembolism; Tissue Plasminogen Activator; Treatment Outcome; Vasodilator Agents; Venous Thrombosis | 2004 |
Tumor necrosis factor alpha and glutathione interplay in chronic heart failure.
Topics: Acetylcysteine; Animals; Cardiotonic Agents; Glutathione; Heart Failure; Humans; Myocardial Contraction; Myocardial Ischemia; Tumor Necrosis Factor-alpha | 2005 |
[Iodinated contrast agent-induced nephropathy].
Topics: Acetylcysteine; Acute Kidney Injury; Age Factors; Angiography; Clinical Trials as Topic; Contrast Media; Diabetes Complications; Free Radical Scavengers; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Renal Replacement Therapy; Risk Factors; Theophylline; Tomography, X-Ray Computed; Vasodilator Agents | 2007 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Fenoldopam; Free Radical Scavengers; Heart Failure; Humans; Iatrogenic Disease; Kidney Diseases; Kidney Transplantation; Multivariate Analysis; Osmolar Concentration; Phosphodiesterase Inhibitors; Prognosis; Renal Dialysis; Risk Factors; Theophylline | 2008 |
2 trial(s) available for acetylcysteine and Heart Failure
| Article | Year |
|---|---|
Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Chi-Square Distribution; Contrast Media; Cystatin C; Female; Germany; Heart Failure; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Radiography; Recurrence; Risk Assessment; Risk Factors; Single-Blind Method; Time Factors; Treatment Outcome; Up-Regulation | 2011 |
Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure.
Topics: Acetylcysteine; Adult; Aged; Atrial Natriuretic Factor; Catecholamines; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Renin | 1994 |
31 other study(ies) available for acetylcysteine and Heart Failure
| Article | Year |
|---|---|
Oral N-acetylcysteine as an adjunct to standard medical therapy improved heart function in cases with stable class II and III systolic heart failure.
Topics: Acetylcysteine; Heart Failure; Heart Failure, Systolic; Humans; Iran; Stroke Volume; Ventricular Function, Left; Ventricular Function, Right | 2022 |
Therapeutic targeting of mitochondrial ROS ameliorates murine model of volume overload cardiomyopathy.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiomyopathies; Disease Models, Animal; Heart Failure; Male; Mice, Inbred C57BL; Mitochondria; Molecular Targeted Therapy; Myocytes, Cardiac; Reactive Oxygen Species | 2019 |
Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Female; Fluid Therapy; Free Radical Scavengers; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Renal Insufficiency, Chronic; Saline Solution; Sodium Bicarbonate; United States; Veterans Health Services | 2020 |
Enhanced oxidative stress mediates pathological autophagy and necroptosis in cardiac myocytes in pressure overload induced heart failure in rats.
Topics: Acetylcysteine; Animals; Autophagy; Blood Pressure; Echocardiography; Heart Failure; Male; Myocytes, Cardiac; Necroptosis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 2022 |
TP53 alteration determines the combinational cytotoxic effect of doxorubicin and an antioxidant NAC.
Topics: A549 Cells; Acetylcysteine; Antioxidants; Apoptosis; Cell Proliferation; Doxorubicin; Drug Synergism; Heart Failure; Humans; MCF-7 Cells; Neoplasms; Phosphorylation; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2017 |
N-Acetylcysteine Influence on Oxidative Stress and Cardiac Remodeling in Rats During Transition from Compensated Left Ventricular Hypertrophy to Heart Failure.
Topics: Acetylcysteine; Animals; Antioxidants; Aortic Valve Stenosis; Glutathione; Heart Failure; Hypertrophy, Left Ventricular; Male; MAP Kinase Signaling System; Oxidative Stress; Rats, Wistar | 2017 |
N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A-type lamins gene.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiomyopathy, Dilated; Disease Models, Animal; Glutathione; Heart; Heart Failure; Heart Ventricles; Humans; Lamin Type A; Mice; Mutation; Myocardium; Oxidative Stress | 2018 |
Evaluation of the Possibility of Correction of Doxorubicin-Induced Chronic Heart Failure in the Experiment with 3-Hydroxypyridine Acetylcysteinate and 3-Hydroxypyridine Succinate.
Topics: Acetylcysteine; Alanine Transaminase; Animals; Antibiotics, Antineoplastic; Antioxidants; Cardiotonic Agents; Catalase; Creatine Kinase, MB Form; Doxorubicin; Heart; Heart Failure; Injections, Intraperitoneal; Malondialdehyde; Picolines; Potassium; Pyridines; Rats; Urea | 2018 |
N-acetylcysteine reduces oxidative stress, nuclear factor‑κB activity and cardiomyocyte apoptosis in heart failure.
Topics: Acetylcysteine; Animals; Apoptosis; bcl-2-Associated X Protein; Dinoprost; Disease Models, Animal; Glutathione; Heart Failure; Hemodynamics; I-kappa B Proteins; Myocardium; Myocytes, Cardiac; NF-KappaB Inhibitor alpha; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rabbits; Transcription Factor RelA | 2014 |
Influence of N- acetylcysteine on oxidative stress in slow-twitch soleus muscle of heart failure rats.
Topics: Acetylcysteine; Animals; Ethidium; Free Radical Scavengers; Glutathione Peroxidase; Heart Failure; Heart Ventricles; Male; Malondialdehyde; Muscle, Skeletal; Myocardial Infarction; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Tyrosine | 2015 |
Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Topics: Acetylcysteine; Animals; Apoptosis; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cardiomyopathy, Dilated; Cells, Cultured; Disease Progression; Gene Expression Profiling; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Ion Channels; Male; Mice; Mice, Knockout; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Proteins; Myocytes, Cardiac; Oxidative Stress; Point Mutation; PPAR alpha; Pressure; Rats; Reactive Oxygen Species; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sequence Analysis, RNA; Sulfonamides; Transfection; Uncoupling Protein 3 | 2015 |
Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure.
Topics: Acetylcysteine; Animals; Bortezomib; Diaphragm; Heart Failure; Humans; Mitochondria; Monocrotaline; Muscle, Skeletal; NF-kappa B; Oxidative Stress; Proteolysis; Rats | 2016 |
Improving Intravenous Fluid Therapy for Prevention of Contrast-Induced Nephropathy: How to Give More Without Causing Heart Failure.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Creatinine; Fluid Therapy; Heart Failure; Humans; Kidney Diseases | 2016 |
N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure.
Topics: Acetylcysteine; Animals; Antioxidants; Collagen Type I; Collagen Type III; Disease Models, Animal; Fibrosis; Genetic Predisposition to Disease; Heart Failure; Male; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Oxidative Stress; Phenotype; Protein Serine-Threonine Kinases; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Oxidative Stress Induced Ventricular Arrhythmia and Impairment of Cardiac Function in Nos1ap Deleted Mice.
Topics: Acetylcysteine; Adaptor Proteins, Signal Transducing; Animals; Antioxidants; Death, Sudden, Cardiac; Electrocardiography; Heart Failure; Mice; Mice, Knockout; Models, Cardiovascular; Oxidative Stress; Polymorphism, Single Nucleotide; Tachycardia, Ventricular | 2016 |
Modulation of MAPK and NF-954;B Signaling Pathways by Antioxidant Therapy in Skeletal Muscle of Heart Failure Rats.
Topics: Acetylcysteine; Animals; Antioxidants; Blotting, Western; Echocardiography; Gene Expression; Heart Failure; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Skeletal; Myocardial Infarction; MyoD Protein; Myogenin; NF-kappa B; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Ventricular Dysfunction, Left | 2016 |
Chronic heart failure and the substrate for atrial fibrillation.
Topics: Acetylcysteine; Action Potentials; Animals; Atrial Fibrillation; Atrial Function, Left; Calcium Channels, L-Type; Calcium Signaling; Cardiac Pacing, Artificial; Chronic Disease; Disease Models, Animal; Dogs; Female; Fibrosis; Heart Conduction System; Heart Failure; Male; Myocardial Contraction; Myocardium; Oxidation-Reduction; Oxidative Stress; Pilot Projects; Potassium Channels; Receptor, Angiotensin, Type 1; Refractory Period, Electrophysiological; Time Factors; Ventricular Function, Left | 2009 |
Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiomyopathies; Collagen; Cytokines; Disease Models, Animal; Heart Failure; HSP27 Heat-Shock Proteins; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Reactive Oxygen Species; Receptors, Adrenergic, beta-2; RNA, Messenger; Signal Transduction; Ventricular Remodeling | 2011 |
Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamsters.
Topics: Acetylcholine; Acetylcysteine; Age Factors; Animals; Antioxidants; Aorta, Thoracic; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cricetinae; Disease Models, Animal; Disease Progression; Echocardiography; Heart Failure; Male; Mesocricetus; Oxidative Stress; Time Factors | 2011 |
Subendocardial increase in reactive oxygen species production affects regional contractile function in ischemic heart failure.
Topics: Acetylcysteine; Animals; Antioxidants; Calcium; Catalase; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Catalytic Subunits; Cyclic AMP-Dependent Protein Kinases; Heart Failure; Lipid Peroxidation; Male; Mitochondria, Heart; Myocardial Contraction; Myocardial Ischemia; Myocytes, Cardiac; Myofibrils; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Recombinant Proteins; Superoxide Dismutase | 2013 |
Cocaine increases intracellular calcium and reactive oxygen species, depolarizes mitochondria, and activates genes associated with heart failure and remodeling.
Topics: Acetylcysteine; Animals; Calcium; Calcium Channel Blockers; Cocaine; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Glutathione; Heart Failure; Intracellular Membranes; Membrane Potentials; Microscopy, Confocal; Mitochondria; Myocytes, Cardiac; Narcotics; Oligonucleotide Array Sequence Analysis; Rabbits; Reactive Oxygen Species; Transcriptional Activation; Ventricular Function, Left; Ventricular Remodeling | 2005 |
Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats.
Topics: Acetylcysteine; Animals; Cardiotonic Agents; Case-Control Studies; Disease Models, Animal; Echocardiography, Doppler; Glutathione; Heart Failure; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Sphingomyelin Phosphodiesterase; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
TNFR1 and TNFR2 signaling interplay in cardiac myocytes.
Topics: Acetylcysteine; Animals; Antibodies; Calcium; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Survival; Cells, Cultured; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Heart Failure; Male; Myocytes, Cardiac; Phospholipases A2, Cytosolic; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Ribosomal Protein S6 Kinases, 90-kDa; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
Haemodynamic effects of glyceryl trinitrate during continuous 24 hour infusion in patients with heart failure.
Topics: Acetylcysteine; Adult; Blood Pressure; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Time Factors; Vascular Resistance | 1994 |
Chronic obstructive pulmonary disease.
Topics: Acetylcysteine; Aerosols; Anti-Bacterial Agents; Bronchodilator Agents; Chronic Disease; Expectorants; Guaifenesin; Heart Failure; Humans; Humidity; Lung Diseases, Obstructive; Patient Education as Topic; Physical Therapy Modalities; Prednisone | 1975 |
Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine.
Topics: Acetylcysteine; Blood Pressure; Blood Volume; Drug Tolerance; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Neurotransmitter Agents; Nitroglycerin; Vascular Resistance | 1990 |
[Nitrate tolerance and its management by N-acetylcysteine (studies of patients with severe chronic heart failure)].
Topics: Acetylcysteine; Cardiomyopathy, Dilated; Coronary Disease; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin | 1989 |
Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
Topics: Acetylcysteine; Administration, Oral; Adult; Aged; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Sulfhydryl Compounds | 1987 |
Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs.
Topics: Acetylcysteine; Animals; Cardiac Catheterization; Dogs; Doxorubicin; Free Radicals; Heart; Heart Failure | 1985 |
[Modern trends in therapy of chronic pulmonary hypertensive cardiopathy].
Topics: Acetylcysteine; Acidosis, Respiratory; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Bicarbonates; Bloodletting; Bronchodilator Agents; Central Nervous System Stimulants; Diuretics; Heart Failure; Humans; Hypertension, Pulmonary; Hypnotics and Sedatives; Oxygen Inhalation Therapy; Positive-Pressure Respiration; Potassium Chloride; Pulmonary Heart Disease; Sympatholytics | 1971 |
Letter: Silicosis--can the course of the disease be modified?
Topics: Acetylcysteine; Aerosols; Apatites; Diet, Sodium-Restricted; Digitalis Glycosides; Diuretics; Drainage; Heart Failure; Humans; Male; Middle Aged; Positive-Pressure Respiration; Respiratory Function Tests; Silicosis | 1974 |